Aikium Inc.的封面图片
Aikium Inc.

Aikium Inc.

生物技术研究

Berkeley,California 2,938 位关注者

Protein therapeutics via deep learning and synthetic biology for impossible targets

关于我们

Aikium is revolutionizing therapeutics with Yotta-ML2, the world’s first AI-driven trillion-protein screening platform. By unlocking undruggable targets where antibodies and small molecules fail, Aikium pioneers next-generation protein therapeutics for cancer, immune disorders, and beyond—pushing the boundaries of AI-powered drug discovery.

所属行业
生物技术研究
规模
2-10 人
总部
Berkeley,California
类型
私人持股
创立
2022
领域
Protein engineering、Deep learning和Synthetic biology

地点

  • 主要

    2630 Bancroft Way

    US,California,Berkeley,94704

    获取路线

Aikium Inc.员工

动态

相似主页

查看职位

融资

Aikium Inc. 共 4 轮

上一轮

种子前

US$1,500,000.00

Crunchbase 上查看更多信息